Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
10/10/1995 | US5457132 Kit used in the treatment for hypertension using combination therapy involving exogenous calcium and calcium channel blockers |
10/10/1995 | US5457038 Natural killer stimulatory factor |
10/10/1995 | CA1337264C Enzyme immunoassay for detecting hiv antigens in human sera |
10/05/1995 | WO1995026506A1 Methods for detecting calpain activation and indentifying calpain inhibitors |
10/05/1995 | WO1995026403A1 Antibodies against e-selectin |
10/05/1995 | WO1995026365A1 Synthetic peptide based immunogens for the treatment of allergy |
10/05/1995 | WO1995026364A1 Monoclonal antibodies recognizing tie-receptor and their use |
10/05/1995 | WO1995026363A1 Neurotrophin-6: a new member of the neurotrophin family |
10/05/1995 | WO1995026362A1 Peptides for diagnostics and therapeutics |
10/05/1995 | WO1995026203A1 Wound healing |
10/05/1995 | WO1995026196A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
10/05/1995 | WO1995023859A3 Novel forms of t cells costimulatory molecules and uses therefor |
10/05/1995 | WO1995017425A3 Markers of organ rejection |
10/05/1995 | CA2186856A1 Chimeric infectious bursal disease virus cdna clones, expression products and vaccines based thereon |
10/05/1995 | CA2186595A1 Synthetic peptide based immunogens for the treatment of allergy |
10/05/1995 | CA2186455A1 Antibodies against e-selectin |
10/05/1995 | CA2185141A1 Methods for detecting calpain activation and indentifying calpain inhibitors |
10/04/1995 | EP0675203A1 Integrationvectors for producing genes, which produce recombinant antibodies |
10/04/1995 | EP0675201A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
10/04/1995 | EP0675200A1 A FAS ligand, a fragment thereof and DNA encoding the same |
10/04/1995 | EP0675199A2 A DNA which codes for the variable region of the anti-human influenza A type virus antibody recognizing the H,N, and H2N2 subtypes of haemagglutinin |
10/04/1995 | EP0675136A2 Antibodies to mammalian interleukin-4 and peptides useful as antigens in their production |
10/04/1995 | EP0674734A1 Runway-maintenance device. |
10/04/1995 | EP0674710A1 Peptides and anti-sense peptides with broad neoplastic specificity |
10/04/1995 | EP0674661A1 Assay and treatment for demyelinating diseases such as multiple sclerosis |
10/04/1995 | EP0674659A1 Peptides and vaccines derived from nematode tubulin |
10/04/1995 | EP0674656A1 Recombinant mammalian calcitonin receptors and uses thereof |
10/04/1995 | EP0547059B1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies |
10/04/1995 | EP0529019B1 Nematode vaccine |
10/04/1995 | CN1109505A Interferon-alpha/beta binding protein, its preparation and use |
10/04/1995 | CN1109469A Macrocyclic bifunctional chelants, complexes threof and their antibody conjugates |
10/03/1995 | US5455337 Treatment of asthma, helminth infections |
10/03/1995 | US5455331 Enriched whey protein fractions and method for the production thereof |
10/03/1995 | US5455330 Isolated pure protein having specified amino acid sequence |
10/03/1995 | US5455179 Quantitative analysis using polypeptide |
10/03/1995 | US5455031 Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit and diagnostic method |
10/03/1995 | US5455030 Immunotheraphy using single chain polypeptide binding molecules |
09/28/1995 | WO1995025813A1 Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene |
09/28/1995 | WO1995025809A1 Compacted nucleic acids and their delivery to cells |
09/28/1995 | WO1995025795A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
09/28/1995 | WO1995025794A1 Anti-igf-i monoclonal antibody |
09/28/1995 | WO1995025740A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
09/28/1995 | WO1995025739A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof |
09/28/1995 | WO1995025543A1 Methods and compositions useful for inhibition of angiogenesis |
09/28/1995 | WO1995025540A1 Method for reducing immune and hemostatic dysfunctions during extracorporeal circulation |
09/28/1995 | WO1995025530A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
09/28/1995 | WO1995025528A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection |
09/28/1995 | WO1994025597A3 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA) |
09/28/1995 | CA2186108A1 Method for reducing immune and hemostatic dysfunctions during extracorporeal circulation |
09/28/1995 | CA2186016A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection |
09/28/1995 | CA2186006A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
09/28/1995 | CA2186005A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof |
09/27/1995 | EP0674178A2 Cyclosporin immunoassay |
09/27/1995 | EP0674176A1 Electrochemiluminescent rhenium moieties and methods of production |
09/27/1995 | EP0674175A2 Chemical modification of antibodies and antigens |
09/27/1995 | EP0674003A2 Modulatory proteins of human CNS receptors |
09/27/1995 | EP0673948A1 Pepticles derived from a retrovirus of the HIV-group and their use |
09/27/1995 | EP0673440A1 Mammalian muscle nad:arginine adp-ribosyltransferase |
09/27/1995 | EP0673426A1 Platelet-activating factor acetylhydrolase |
09/27/1995 | EP0673425A1 Dna encoding chitin deacetylase |
09/27/1995 | EP0673418A1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
09/27/1995 | EP0673417A1 LIGAND BINDING VARIABLE DOMAIN (V-MIN) COMPRISING A FRAMEWORK REGION WITH A CYCLICALLY PERMUTED CENTRAL $g(b)-BARREL |
09/27/1995 | EP0673391A1 Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto |
09/27/1995 | EP0673390A1 Delta-like gene expressed in neuroendocrine tumors |
09/27/1995 | EP0673389A1 Antibodies for gm-csf receptor and uses thereof |
09/27/1995 | EP0673255A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
09/27/1995 | EP0593460B1 Method and apparatus for biopolymer synthesis |
09/27/1995 | EP0348490B1 Treatment of type 2 diabetes mellitus |
09/27/1995 | EP0261225B1 Lectin complex and method and probe for making same |
09/27/1995 | CN1109260A A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
09/26/1995 | US5453371 Bacterial collagenase gene of Vibrio alginolyticus |
09/26/1995 | US5453362 Herpes virus, viricides |
09/26/1995 | US5453361 Method for producing biologically active human brain derived neurotrophic factor |
09/26/1995 | US5453359 Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers |
09/26/1995 | US5453354 Method for improving sperm motility |
09/26/1995 | US5453269 Heterobifunctional antibodies having dual specificity for fibrin and thrombolylic agents and methods of use |
09/26/1995 | CA2145623A1 Modulatory proteins of human cns receptors |
09/22/1995 | CA2144936A1 Antibody conjugates with improved properties |
09/21/1995 | WO1995025173A1 Methods for identifying inhibitors of integrin activation |
09/21/1995 | WO1995025172A1 Recombinant antibody fragments which are synthesized and biotinylated in e. coli, their use in immunoassays and immunopurification techniques |
09/21/1995 | WO1995025167A1 Anti-egfr single-chain fvs and anti-egfr antibodies |
09/21/1995 | WO1995025126A1 Antibodies to interleukin-8 receptors and methods of use |
09/21/1995 | WO1995025125A1 Dna encoding cai resistance proteins and uses thereof |
09/21/1995 | WO1995025117A1 Polypeptides of lipopolysaccharide binding protein |
09/21/1995 | WO1995025113A1 Synthetic compounds which bind to h. pylori, and uses thereof |
09/21/1995 | WO1995024927A1 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins |
09/21/1995 | WO1995024922A1 Chlamydia vaccines and process |
09/21/1995 | WO1995024921A1 A medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction |
09/21/1995 | WO1995024918A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
09/21/1995 | WO1995024917A1 Skin treatment composition |
09/21/1995 | WO1995024916A1 Retropeptides, antibodies thereto, and uses thereof for vaccination and in vitro diagnosis |
09/21/1995 | WO1995024913A1 Treatment of graft-versus-host disease |
09/21/1995 | WO1995024904A1 Synergistic inhibition of hiv-1 infection using a nucleoside reverse transcriptase inhibitor and anti-hiv-1 antibodies |
09/21/1995 | WO1995018826A3 Purified primate ctla-8 antigens and related reagents |
09/21/1995 | DE4406813A1 Filter layer with monoclonal antibody for allergen removal |
09/21/1995 | CA2185446A1 Methods for identifying inhibitors of integrin activation |
09/21/1995 | CA2185341A1 Dna encoding cai resistance proteins and uses thereof |
09/21/1995 | CA2184269A1 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins |
09/21/1995 | CA2181162A1 Skin treatment composition |
09/20/1995 | EP0672756A1 Monoclonal antibody recognizing fk506-binding protein, method of assaying fk506-binding protein level, and kit thereof |